In Vitro\Ex Vivo Generation of Cytotoxic T Lymphocytes
- 30 June 2014
- book chapter
- Published by Springer Nature
- Vol. 1186, 13-20
Abstract
The in vitro generation of human cytotoxic T lymphocytes (CTL) is a reliably approach useful not only to assess intrinsic CD8+ T cell responses in individuals but also to screen immunogenic antigens that could be considered as candidates for adoptive immunotherapeutic approaches. In vitro methods to expand CTL require culturing naïve T cells with antigen-presenting cells (APC) as stimulator cells that express specific antigens. Here, we describe the protocol for generating CTL against target antigens presented by monocyte-derived dendritic cells (DCs).Keywords
This publication has 8 references indexed in Scilit:
- Interferon-alpha (IFN-α)–conditioned DC Preferentially Stimulate Type-1 and Limit Treg-type In Vitro T-cell Responses From RCC PatientsJournal of Immunotherapy, 2008
- Effector and Memory CTL DifferentiationAnnual Review of Immunology, 2007
- In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoireJournal of Immunological Methods, 2006
- Dendritic Cells in Tumor Immunology and ImmunotherapyCurrent Drug Targets, 2004
- A Pilot Trial of Tumor Lysate-Loaded Dendritic Cells for the Treatment of Metastatic Renal Cell CarcinomaJournal of Immunotherapy, 2003
- Generation of antigen-loaded dendritic cells in a serum-free medium using different cytokine combinationsVaccine, 2002
- In vitro induction of tumor-specific human lymphocyte antigen class I–restricted CD8+ cytotoxic T lymphocytes by ovarian tumor antigen–pulsed autologous dendritic cells from patients with advanced ovarian cancerAmerican Journal of Obstetrics and Gynecology, 2000
- Measurement of Polyclonal and Antigen-Specific Cytotoxic T Cell FunctionCurrent Protocols in Immunology, 1996